AkzoNobel stock holds at EUR 56.68 as margins expand

Published on 10/03/2026 at 23:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

AkzoNobel stock posted Q2 adjusted EBITDA of EUR 398 million, up 5 percent at comparable scope. Management kept its EUR 1.47 billion 2026 target.

Glasfassaden-Zentrale nahe Chemieanlage, passend zu Akzo Nobel N.V — Architektur-Render zeigt moderne Konzernzentrale neben Chemieanlage, passend zu Akzo Nobel N.V., ISIN NL0013267909, in Amsterdam, Illustration mit AI erstellt.

AkzoNobel (ISIN NL0013267909) was trading at EUR 56.68 on Euronext Amsterdam on October 2, 2026, while its latest quarter showed adjusted EBITDA of EUR 398 million, up 5 percent at comparable scope. Ideal Investisseur reported on September 30, 2026, that the company completed the sale of its Pakistani subsidiary to IGI Investments.

Portfolio review advances

The Pakistan transaction is part of AkzoNobel's portfolio review as the coatings group concentrates capital and management attention on its core businesses. The sale adds a concrete execution point to the company's broader strategic reshaping ahead of the planned combination with Axalta.

AkzoNobel's second-quarter adjusted EBITDA margin reached 15.4 percent, up 40 basis points year over year, according to the Yahoo Finance transcript dated July 22, 2026. Organic sales increased 2 percent, with pricing up 3 percent and volumes stable, although total revenue declined 1 percent.

Margin progress meets valuation debate

Management maintained its 2026 adjusted EBITDA target at or above EUR 1.47 billion, while the Q2 call described the margin expansion as the fifth consecutive year-over-year improvement. The comparison matters because pricing gains are being used to offset raw-material inflation while volumes remain broadly stable.

JPMorgan resumed coverage at Overweight with a EUR 72 price target on September 24, 2026, according to Finanznachrichten. That target lies 27.1 percent above the EUR 56.68 reference price, putting the market's assessment of execution and merger benefits alongside the company's operating targets.

October results set the next test

Investing.com lists October 21, 2026, as AkzoNobel's next earnings date. The release will give investors a fresh check on pricing, volume resilience and progress toward the EUR 1.47 billion adjusted EBITDA target.

Stock remains below yearly high

AkzoNobel stock was trading at EUR 56.68 on Euronext Amsterdam on October 2, 2026. Its 52-week range was EUR 46.18 to EUR 67.64, leaving the price EUR 10.96 below the yearly high.